title: Mosaic distribution of chondroitin and keratan sulphate in the developing rat striatum: possible involvement of proteoglycans in the organization of the nigrostriatal system.
abstract: The striatum of the mammalian basal ganglia is composed of two neurochemically distinct compartments termed patches and matrix that contribute overall to a mosaic organization. Glycosaminoglycans (GAGs), the sugar moieties of proteoglycans, provide specific spatio-temporal guidance cues during the development of several functional neural systems. However, their distribution within the nigrostriatal system has not been investigated yet. Here, the immunohistochemical distributions of unsulphated (C0S), 4-sulphated (C4S) and 6-sulphated chondroitin (C6S) and keratan sulphate (KS) were examined in the developing neostriatum of rat and compared with the distribution of dopaminergic terminals. All the chondroitin sulphate (CS) isomers are homogeneously expressed in the embryonic striatum. After birth, C0S and C6S reveal the striatal mosaic in being preferentially expressed within the matrix compartment and in boundaries around patches whereas the C4S epitope is present in both compartments, with a slight patchy distribution. KS expression is detected first in the patches during the early postnatal period and subsequently only in the matrix compartment. All these GAG expressions disappear as the brain matures except for C4S which remains high throughout adult life. Furthermore, studies within the developing medial forebrain bundle reveal that CS isomers, but not KS, are expressed in and around the dopamine axonal tract but show similar developmental patterns of distribution which do not appear to be specifically associated with the nigrostriatal pathway. These results suggest a possible implication of proteoglycans during the development of the striatum and may be useful for understanding the complex cellular and molecular interactions in degeneration and plasticity of the nigrostriatal circuit in Parkinson's disease.
authors.affiliation: Laboratoire de Neurobiologie du Développement, LAPSEN, INSERM U318, Université Joseph Fourier, CERMO, BP 53, 38041, Grenoble, Cedex 9, France. igor.charvet@uif-grenoble.fr
authors.forename: I
authors.initials: I
authors.lastname: Charvet
authors.forename: F J
authors.initials: FJ
authors.lastname: Hemming
authors.forename: C
authors.initials: C
authors.lastname: Feuerstein
authors.forename: R
authors.initials: R
authors.lastname: Saxod
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D002807:Chondroitin / Q000378:metabolism*; D000939:Epitopes; D005260:Female; D007150:Immunohistochemistry; D007632:Keratan Sulfate / Q000378:metabolism*; D017072:Neostriatum / Q000254:growth & development / Q000378:metabolism*; D011247:Pregnancy; D011509:Proteoglycans / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D013378:Substantia Nigra / Q000254:growth & development / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D000939:Epitopes; D011509:Proteoglycans; D002807:Chondroitin; D007632:Keratan Sulfate